[Therapeutic monitoring of amikacin and gentamicin in routine clinical practice]

Vnitrni Lekarstvi
|February 20, 2015
PubMed

Insights

Aminoglycosides are effective antimicrobials, but can be toxic. Extended interval dosing reduces toxicity and improves outcomes, with therapeutic drug monitoring optimizing their use.

Area of Science:

  • Pharmacology
  • Infectious Diseases
  • Clinical Pharmacy

Background:

  • Aminoglycosides are essential antimicrobials for aerobic gram-negative infections and synergistic gram-positive therapy.
  • Despite known nephrotoxicity and ototoxicity, their clinical value persists.
  • These agents exhibit concentration-dependent bactericidal effects and a notable post-antibiotic effect.

Purpose of the Study:

  • To review the efficacy and toxicity of aminoglycosides.
  • To highlight the benefits of extended interval dosing.
  • To emphasize the role of therapeutic drug monitoring in optimizing aminoglycoside therapy.

Main Methods:

  • Literature review of aminoglycoside pharmacology, clinical use, and toxicity.
  • Analysis of evidence supporting extended interval dosing strategies.
  • Discussion of therapeutic drug monitoring principles for aminoglycosides.

Main Results:

  • Extended interval dosing of aminoglycosides is associated with reduced nephrotoxicity and ototoxicity.
  • Clinical outcomes with extended interval dosing are comparable or superior to traditional multiple daily dosing.
  • Aminoglycoside efficacy and toxicity are directly related to blood drug concentrations.

Conclusions:

  • Extended interval dosing represents an optimized strategy for aminoglycoside administration.
  • Therapeutic drug monitoring is crucial for minimizing aminoglycoside toxicity and maximizing efficacy.
  • Aminoglycosides remain valuable agents when administered and monitored appropriately.

Related Concept Videos

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
362
Estimation of k and VD of Aminoglycosides01:20

Estimation of k and VD of Aminoglycosides

Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
311
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
518
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
394
Therapeutic Drug Monitoring: Overview and Classification01:16

Therapeutic Drug Monitoring: Overview and Classification

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
574
Therapeutic Drug Monitoring: Drug Analysis Methods01:26

Therapeutic Drug Monitoring: Drug Analysis Methods

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
323